K-S Eom

734 citations

19 papers · 542 · h-index 13

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Transplantation top 5%
- Renal Transplantation Outcomes and Treatments

Papers in

Hematology 16
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 6
Public Health, Environmental and Occupational Health 7
- Acute Lymphoblastic Leukemia research 7

Co-authors: W-S Min (17 shared papers)YJ Kim (15 shared papers)JW Lee (15 shared papers)C-K Min (15 shared papers)B-S Cho (15 shared papers)C-C Kim (8 shared papers)Se Lee (10 shared papers)Seung‐Hwan Lee (3 shared papers)
Journals: Bone Marrow Transplantation (13 papers)Leukemia (4 papers)Mucosal Immunology (1 paper)Journal of Korean Neurosurgical Society (1 paper)
Partner nations: South Korea United States United Kingdom

In The Last Decade

K-S Eom

18 papers receiving 539 citations

Peers

Countries citing papers authored by K-S Eom

Since Specialization

Citations

This map shows the geographic impact of K-S Eom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K-S Eom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K-S Eom more than expected).

Fields of papers citing papers by K-S Eom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K-S Eom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K-S Eom. The network helps show where K-S Eom may publish in the future.

Co-authors

The 24 scholars most cited alongside K-S Eom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K-S Eom Line = papers co-authored together K-S Eom links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Feasibility of NIH consensus criteria for chronic graft-versus-host disease Leukemia ·B-S Cho, C-K Min, K-S Eom, YJ Kim, (unknown), Sang Ho Lee, (unknown), (unknown), JW Lee, W-S Min, C-C Kim	2008	92
2	Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia Leukemia ·Seung‐Hwan Lee, (unknown), B-S Cho, (unknown), (unknown), S-A Yahng, Se Lee, K-S Eom, YJ Kim, Chung Ng, (unknown), C-K Min, JW Lee, W-S Min, C.K. Park, C.K. Park	2012	82
3	Risk and prognostic factors for acute GVHD based on NIH consensus criteria Bone Marrow Transplantation ·Se Lee, B-S Cho, (unknown), (unknown), (unknown), S-A Yahng, K-S Eom, YJ Kim, (unknown), Seung‐Hwan Lee, C-K Min, (unknown), (unknown), JW Lee, W-S Min, C.K. Park	2012	73
4	Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplantation ·B-S Cho, C-K Min, K-S Eom, YJ Kim, (unknown), Sung Kyun Lee, (unknown), Y Kim, (unknown), JW Lee, W-S Min, C-C Kim	2008	57
5	Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study Leukemia ·B-S Cho, Sae-Mi Lee, YJ Kim, Chung Ng, K-S Eom, (unknown), C-K Min, (unknown), (unknown), JW Lee, W-S Min, C-C Kim	2009	55
6	Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation Bone Marrow Transplantation ·(unknown), (unknown), Jae Woo Kim, (unknown), (unknown), Se Lee, B-S Cho, K-S Eom, YJ Kim, Soo‐Jin Lee, C-K Min, (unknown), JW Lee, W-S Min, C-W Park	2014	31
7	Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia Leukemia ·SoJung Lee, Chung Ng, B-S Cho, K-S Eom, YJ Kim, (unknown), C-K Min, (unknown), (unknown), JW Lee, W-S Min, C-W Park, C-C Kim	2010	20
8	Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission Bone Marrow Transplantation ·(unknown), W-S Min, K-S Eom, (unknown), YH Park, (unknown), JW Lee, C-W Park, C-C Kim	2004	20
9	Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA? Bone Marrow Transplantation ·(unknown), W-S Min, H.J. Kim, (unknown), (unknown), S-A Yahng, Se Lee, B-S Cho, K-S Eom, YJ Kim, So Jung Lee, C-K Min, (unknown), (unknown), JW Lee, C.K. Park	2013	18
10	Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia Bone Marrow Transplantation ·Se Lee, S-A Yahng, B-S Cho, K-S Eom, YJ Kim, (unknown), C-K Min, Sang Ho Lee, (unknown), (unknown), W-S Min, Jin Won Lee	2016	17
11	Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL Bone Marrow Transplantation ·Myungshin Kim, J Park, (unknown), YJ Kim, (unknown), (unknown), (unknown), S-A Yahng, Se Lee, B-S Cho, K-S Eom, (unknown), C-Ki Min, (unknown), Y Kim, JW Lee, Kyungja Han, W-S Min, Sae-Mi Lee	2014	17
12	MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease Mucosal Immunology ·J-Y Lim, (unknown), Se Lee, Ji-Min Ju, K-S Eom, YJ Kim, Chung Ng, Dae-Chul Jeong, G Park, Eun Young Choi, C-K Min	2015	14
13	Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure Bone Marrow Transplantation ·(unknown), S-A Yahng, (unknown), Se Lee, B-S Cho, K-S Eom, Seung‐Hwan Lee, C-K Min, (unknown), (unknown), (unknown), JW Lee, W-S Min, C.K. Park, YJ Kim	2012	12
14	Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia Bone Marrow Transplantation ·(unknown), W-S Min, K-S Eom, B-S Cho, (unknown), J.N. Bok, (unknown), C-K Min, Soo‐Jin Lee, (unknown), (unknown), JW Lee, C-C Kim	2007	12
15	Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome Bone Marrow Transplantation ·S-A Yahng, (unknown), (unknown), (unknown), Se Lee, Y-S Choi, Do Young ‍Kim, (unknown), B-S Cho, K-S Eom, Sang Ho Lee, C-K Min, (unknown), JW Lee, (unknown), W-S Min, (unknown), YJ Kim, Je‐Hwan Lee	2016	10
16	Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT Bone Marrow Transplantation ·M-J Park, H-B Choi, J.‐P. Jang, (unknown), YJ Kim, K-S Eom, Sung Kyun Lee, (unknown), JW Lee, W-S Min, C-C Kim, T-G Kim	2007	5
17	PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL Bone Marrow Transplantation ·(unknown), (unknown), S-A Yahng, Se Lee, B-S Cho, K-S Eom, Y-J Kim, H-J Kim, C-K Min, (unknown), D-W Kim, J. W. Lee, W-S Min, C.K. Park, Sung Kyun Lee	2014	4
18	Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML Bone Marrow Transplantation ·(unknown), W-S Min, B-S Cho, K-S Eom, (unknown), YJ Kim, Soo‐Jin Lee, C-K Min, (unknown), JW Lee, C-C Kim	2009	3
19	Giant Osteoma of the Anterior Cranial Fossa: Case Report. Journal of Korean Neurosurgical Society ·K-S Eom, Kim Ty, J M Kim	2002	0

About K-S Eom

K-S Eom is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Rheumatology and Immunology, having authored 19 papers that have together received 542 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Vascular Tumors and Angiosarcomas (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Polyomavirus and related diseases (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Hematology (424 citations), Transplantation (49 citations), Public Health, Environmental and Occupational Health (200 citations), Immunology (121 citations) and Genetics (59 citations). K-S Eom has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include W-S Min, YJ Kim, JW Lee, C-K Min, B-S Cho, C-C Kim, Se Lee, Seung‐Hwan Lee, Sang Ho Lee and Sung Kyun Lee. Their work appears in journals such as Bone Marrow Transplantation, Leukemia, Mucosal Immunology and Journal of Korean Neurosurgical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

K-S Eom

Impact in

Papers in i

In The Last Decade

K-S Eom

Peers

Countries citing papers authored by K-S Eom

Fields of papers citing papers by K-S Eom

All Works

About K-S Eom

Explore authors with similar magnitude of impact

Papers in